NYSE · UNH
UnitedHealth Group Incorporated
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
Loading market information…
NYSE · ELV · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Elevance Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.36% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Elevance Health Inc.’s forward annual dividend is $6.88 per share, paid quarterly. The forward yield is 1.63% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Elevance Health Inc.’s next earnings report is currently expected on Jan 27, 2027, with estimated earnings per share of $2.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Elevance Health Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 17, 2025 | $8.84-0.79% vs estimate | $49.42B+2.55% vs estimate |
|---|
| Q1 2025 | Apr 22, 2025 | $11.97+4.91% vs estimate | $48.77B+5.32% vs estimate |
|---|
| Q4 2024 | Jan 23, 2025 | $3.84+1.05% vs estimate | $45.44B+1.09% vs estimate |
|---|
KEEP COMPARING
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
$90.33+$0.38 (+0.42%)
CVS Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 18.39% below the high.
$298.41+$3.41 (+1.16%)
Cigna Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.65% below the high.
$417.56+$5.69 (+1.38%)
Humana Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.53% below the high.
$68.62+$1.57 (+2.34%)
Centene Corp.’s quoted price sits in the upper half of its reported 52-week range, 5.35% below the high.
$198.95+$0.85 (+0.43%)
Molina Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.76% below the high.
$30.79+$0.31 (+1.02%)
Oscar Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.05% below the high.
$8.06-$0.12 (-1.47%)
Alignment Healthcare, Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.91% below the high.
THE ANALYST VIEW
38 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 16 contributors · Median target $474.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
